CP
BIIB icon

Corbenic Partners’s Biogen BIIB Stock Holding History

Corbenic Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11
Closed -$3K – 259
2017
Q2 		$3K Sell
11
-150
-93% -$39.7K ﹤0.01% 145
2017
Q1 		$44K Buy
161
+11
+7% +$3.11K 0.05% 72
2016
Q4 		$43K Buy
+150
New +$44.5K 0.05% 74
2015
Q1 		– Sell
-27
Closed -$9K – 166
2014
Q4 		$9K Buy
+27
New +$8.73K 0.01% 128

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Corbenic Partners's BIIB Position: Q3 2017 in Review

Corbenic Partners sold out of Biogen (BIIB) in Q3 2017, closing a stake of 11 shares — an estimated $3K sold.

Corbenic Partners first reported a position in BIIB in Q4 2014 and held it in 4 quarters. The position peaked at $44K in Q1 2017. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Corbenic Partners reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
  • Corbenic Partners sold 11 Biogen shares in Q3 2017, an estimated $3K.
  • Corbenic Partners first reported a position in Biogen in Q4 2014 and held it in 4 quarters.
  • Corbenic Partners's Biogen position peaked at $44K in Q1 2017.
  • 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Corbenic Partners's 13F filing for Q3 2017, filed 26 Oct 2017.